Description générale
Trastuzumab is a monoclonal antibody used in the treatment of human epidermal growth factor receptor 2 positive (HER2+) breast cancer.
INN
Trastuzumab
Codes ATC
Type de médicament
Biological agent
Historique des statuts LME
Ajouté pour la première fois en 2015
(TRS
994)
pour
Carcinoma of breast, specialised type
Wikipédia
DrugBank
Recommandations
Section
Targeted therapies
- Parenteral > General injections > IV: 60 mg in vial powder for injection; 150 mg in vial powder for injection; 440 mg in vial powder for injection
Indications